Follow
Simon Mallal
Simon Mallal
Director, Institute for Immunology and Infectious Diseases, Murdoch University, Western Australia
Verified email at iiid.com.au
Title
Cited by
Cited by
Year
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
20492003
HLA-B* 5701 screening for hypersensitivity to abacavir
S Mallal, E Phillips, G Carosi, JM Molina, C Workman, J Tomažič, ...
New England Journal of Medicine 358 (6), 568-579, 2008
19262008
Association between presence of HLA-B* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal, D Nolan, C Witt, G Masel, AM Martin, C Moore, D Sayer, ...
The Lancet 359 (9308), 727-732, 2002
16092002
A whole-genome association study of major determinants for host control of HIV-1
J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ...
science 317 (5840), 944-947, 2007
13902007
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
10692008
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA
P Kiepiela, AJ Leslie, I Honeyborne, D Ramduth, C Thobakgale, S Chetty, ...
Nature 432 (7018), 769-775, 2004
9192004
Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level
CB Moore, M John, IR James, FT Christiansen, CS Witt, SA Mallal
Science 296 (5572), 1439-1443, 2002
8992002
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ...
Science 370 (6512), 89-94, 2020
7562020
Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
SA Mallal, M John, CB Moore, IR James, EJ McKinnon
Aids 14 (10), 1309-1316, 2000
6212000
The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases
P Price, C Witt, R Allock, D Sayer, M Garlepp, CC Kok, M French, S Mallal, ...
Immunological reviews 167 (1), 257-274, 1999
5961999
Predisposition to abacavir hypersensitivity conferred by HLA-B* 5701 and a haplotypic Hsp70-Hom variant
AM Martin, D Nolan, S Gaudieri, CA Almeida, R Nolan, I James, ...
Proceedings of the National Academy of Sciences 101 (12), 4180-4185, 2004
5292004
Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy
MA French, N Lenzo, M John, SA Mallal, EJ McKinnon, IR James, P Price, ...
HIV medicine 1 (2), 107-115, 2000
5282000
Adaptation of HIV-1 to human leukocyte antigen class I
Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ...
Nature 458 (7238), 641-645, 2009
5262009
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
D Sulzer, RN Alcalay, F Garretti, L Cote, E Kanter, J Agin-Liebes, C Liong, ...
Nature 546 (7660), 656-661, 2017
4802017
Common genetic variation and the control of HIV-1 in humans
J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ...
PLoS genetics 5 (12), e1000791, 2009
4342009
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
DA Ostrov, BJ Grant, YA Pompeu, J Sidney, M Harndahl, S Southwood, ...
Proceedings of the National Academy of Sciences 109 (25), 9959-9964, 2012
3922012
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune …
S Loi, S Dushyanthen, PA Beavis, R Salgado, C Denkert, P Savas, ...
Clinical Cancer Research 22 (6), 1499-1509, 2016
3912016
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
B Ledergerber, PLATO collaboration
The Lancet 364 (9428), 51-62, 2004
3912004
High sensitivity of human leukocyte antigen-b* 5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
M Saag, R Balu, E Phillips, P Brachman, C Martorell, W Burman, B Stancil, ...
Clinical infectious diseases 46 (7), 1111-1118, 2008
3842008
Effects of CCR5-32, CCR2-64I, and SDF-1 3 A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data
IP Data
Ann Intern Med 135, 782-795, 2001
376*2001
The system can't perform the operation now. Try again later.
Articles 1–20